Smith & Nephew (NYSE:SNN) Receives Neutral Rating from Credit Suisse Group

Smith & Nephew (NYSE:SNN)‘s stock had its “neutral” rating reissued by research analysts at Credit Suisse Group in a research report issued to clients and investors on Tuesday, The Fly reports.

SNN has been the subject of a number of other research reports. Commerzbank downgraded shares of Smith & Nephew from a “buy” rating to a “hold” rating in a report on Monday, February 22nd. JPMorgan Chase & Co. reaffirmed a “neutral” rating on shares of Smith & Nephew in a research report on Monday, February 22nd. Canaccord Genuity lifted their target price on Smith & Nephew from $53.00 to $55.00 and gave the company a “buy” rating in a report on Friday. Berenberg Bank reaffirmed a “buy” rating on shares of Smith & Nephew in a research report on Tuesday, February 23rd. Finally, Zacks Investment Research raised Smith & Nephew from a “strong sell” rating to a “hold” rating in a research report on Tuesday, April 27th. Two research analysts have rated the stock with a sell rating, five have given a hold rating and six have issued a buy rating to the company. The stock has a consensus rating of “Hold” and a consensus price target of $47.83.

SNN stock traded down $1.26 during mid-day trading on Tuesday, reaching $42.24. 28,842 shares of the company’s stock were exchanged, compared to its average volume of 484,845. The company has a market cap of $18.56 billion, a price-to-earnings ratio of 20.74, a price-to-earnings-growth ratio of 4.91 and a beta of 0.70. The stock’s 50 day moving average is $39.28 and its 200 day moving average is $40.46. The company has a debt-to-equity ratio of 0.50, a current ratio of 2.18 and a quick ratio of 1.04. Smith & Nephew has a 12-month low of $34.29 and a 12-month high of $46.10.

Institutional investors have recently made changes to their positions in the business. Franklin Street Advisors Inc. NC raised its holdings in Smith & Nephew by 10.4% during the first quarter. Franklin Street Advisors Inc. NC now owns 5,528 shares of the medical equipment provider’s stock worth $210,000 after purchasing an additional 519 shares in the last quarter. Mount Yale Investment Advisors LLC boosted its holdings in shares of Smith & Nephew by 103.5% in the 1st quarter. Mount Yale Investment Advisors LLC now owns 61,640 shares of the medical equipment provider’s stock valued at $2,336,000 after buying an additional 31,352 shares in the last quarter. Spearhead Capital Advisors LLC grew its position in shares of Smith & Nephew by 7.1% in the 1st quarter. Spearhead Capital Advisors LLC now owns 6,745 shares of the medical equipment provider’s stock valued at $256,000 after buying an additional 449 shares during the last quarter. Comerica Bank raised its stake in Smith & Nephew by 3.1% during the 1st quarter. Comerica Bank now owns 33,934 shares of the medical equipment provider’s stock worth $1,405,000 after acquiring an additional 1,023 shares in the last quarter. Finally, Manning & Napier Group LLC lifted its position in Smith & Nephew by 7.2% in the first quarter. Manning & Napier Group LLC now owns 42,442 shares of the medical equipment provider’s stock valued at $1,608,000 after acquiring an additional 2,851 shares during the last quarter. Institutional investors own 8.91% of the company’s stock.

Smith & Nephew Company Profile

Smith & Nephew plc, together with its subsidiaries, develops, manufactures, markets, and sells medical devices worldwide. The company offers knee implant products for knee replacement procedures; hip implants for the reconstruction of hip joints; and trauma and extremities products that include internal and external devices used in the stabilization of severe fractures and deformity correction procedures.

Further Reading: What are the components of an earnings report?

The Fly

Analyst Recommendations for Smith & Nephew (NYSE:SNN)

Receive News & Ratings for Smith & Nephew Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Smith & Nephew and related companies with MarketBeat.com's FREE daily email newsletter.